Factors influencing islet transplantation. Number, location, and metabolic control.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 2105547)

Published in Transplantation on January 01, 1990

Authors

A Hayek1, A D Lopez, G M Beattie

Author Affiliations

1: Lucy Thorne Whittier Children's Center, Whittier Institute, La Jolla, California 92037.

Articles by these authors

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet (1997) 44.03

Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet (1997) 29.18

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet (1997) 25.40

Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet (1992) 25.28

Evidence-based health policy--lessons from the Global Burden of Disease Study. Science (1996) 13.50

Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med (1997) 8.25

Mortality from smoking worldwide. Br Med Bull (1996) 7.87

Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study. Lancet (1997) 7.29

The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ (1994) 6.99

The global burden of disease, 1990-2020. Nat Med (1998) 6.50

Quantifying disability: data, methods and results. Bull World Health Organ (1994) 4.99

Measuring the accumulated hazards of smoking: global and regional estimates for 2000. Tob Control (2003) 4.94

Armed conflict as a public health problem. BMJ (2002) 4.42

Healthy life expectancy in 191 countries, 1999. Lancet (2001) 4.31

On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. Epidemiology (1999) 3.66

The decline in child mortality: a reappraisal. Bull World Health Organ (2000) 3.46

Global and regional cause-of-death patterns in 1990. Bull World Health Organ (1994) 3.37

Progress and directions in refining the global burden of disease approach: a response to Williams. Health Econ (2000) 3.17

The use of cause-of-death statistics for health situation assessment: national and international experiences. World Health Stat Q (1990) 2.84

The utility of DALYs for public health policy and research: a reply. Bull World Health Organ (1997) 2.49

Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob Control (2004) 2.12

Measuring the burden of disease. Lancet (1998) 1.58

Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells. J Clin Invest (1993) 1.46

At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer (1994) 1.45

Hypertension in developing countries. World Health Stat Q (1988) 1.45

Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes (1999) 1.35

Ex vivo expansion of human pancreatic endocrine cells. J Clin Endocrinol Metab (1997) 1.33

Tobacco or health. World Health Stat Q (1993) 1.32

KSA antigen Ep-CAM mediates cell-cell adhesion of pancreatic epithelial cells: morphoregulatory roles in pancreatic islet development. J Cell Biol (1998) 1.26

Global and regional mortality patterns by cause of death in 1980. Int J Epidemiol (1986) 1.22

Global gene expression profiling and histochemical analysis of the developing human fetal pancreas. Diabetologia (2007) 1.21

Expression and function of alpha(v)beta(3) and alpha(v)beta(5) integrins in the developing pancreas: roles in the adhesion and migration of putative endocrine progenitor cells. J Cell Biol (2000) 1.20

An in vivo model for study of the angiogenic effects of basic fibroblast growth factor. Biochem Biophys Res Commun (1987) 1.19

Accelerated telomere shortening and senescence in human pancreatic islet cells stimulated to divide in vitro. J Endocrinol (2000) 1.18

Counting the dead in China. Measuring tobacco's impact in the developing world. BMJ (1998) 1.14

Growth factor/matrix-induced proliferation of human adult beta-cells. Diabetes (1995) 1.13

Microfabricated immunoisolating biocapsules. Biotechnol Bioeng (1998) 1.13

The incremental effect of age-weighting on YLLs, YLDs, and DALYs: a response. Bull World Health Organ (1996) 1.09

Induction of lymphoma in antigenically stimulated athymic mice. Cancer Res (1982) 1.08

Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes (1994) 1.08

Experimental transplantation of human fetal and adult pancreatic islets. J Clin Endocrinol Metab (1997) 1.05

Induction of sarcomas in athymic mice. Proc Natl Acad Sci U S A (1982) 1.05

On the assessment of maternal mortality. World Health Stat Q (1987) 1.04

A role for activin A and betacellulin in human fetal pancreatic cell differentiation and growth. J Clin Endocrinol Metab (2000) 1.03

Trehalose: a cryoprotectant that enhances recovery and preserves function of human pancreatic islets after long-term storage. Diabetes (1997) 1.02

Sex differentials in mortality. WHO Chron (1984) 1.02

Functional beta-cell mass after transplantation of human fetal pancreatic cells: differentiation or proliferation? Diabetes (1997) 1.00

Phosphatidylinositol 3-kinase is a negative regulator of cellular differentiation. J Cell Biol (1997) 0.99

Reducing child mortality. Bull World Health Organ (2000) 0.94

Isolation and characterization of a cell line from the epithelial cells of the human fetal pancreas. Cell Transplant (1997) 0.92

Epidemiologic surveillance of the tobacco epidemic. MMWR Morb Mortal Wkly Rep (1992) 0.91

Keratinocyte growth factor and beta-cell differentiation in human fetal pancreatic endocrine precursor cells. Diabetologia (2003) 0.89

Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes (1999) 0.88

Developmental gene expression in the human fetal pancreas. Pediatr Res (1994) 0.86

PDX-1 and cell-cell contact act in synergy to promote delta-cell development in a human pancreatic endocrine precursor cell line. Mol Endocrinol (2000) 0.86

Decrease in the number of neonatal islets required for successful transplantation by strict metabolic control of diabetic rats. Transplantation (1988) 0.85

Smoking and death in Russia. Tob Control (1998) 0.84

E2A gene products are not required for insulin gene expression. Endocrinology (1996) 0.83

A note on estimating the cause of death structure in high mortality populations. Popul Bull UN (1982) 0.83

Biological actions of 53 kDa nerve growth factor as studied by a blot and culture technique. Neurosci Lett (1989) 0.81

The use of digital image processing to quantitate angiogenesis induced by basic fibroblast growth factor and transplanted pancreatic islets. Microvasc Res (1991) 0.81

Protection from cell death in cultured human fetal pancreatic cells. Cell Transplant (2000) 0.81

Processing, storage and experimental transplantation of human fetal pancreatic cells. Ann Transplant (1997) 0.81

Transplantation of human fetal pancreas: fresh vs. cultured fetal islets or ICCS. J Mol Med (Berl) (1999) 0.80

Tuberculosis mortality differentials in Indonesia during 2007-2008: evidence for health policy and monitoring. Int J Tuberc Lung Dis (2011) 0.80

Enhancement of pancreatic islet cell monolayer growth by endothelial cell matrix and insulin. In Vitro Cell Dev Biol (1989) 0.79

Induction of T- and B-lymphocyte responses in antigenically stimulated athymic mice. Cancer Res (1981) 0.79

100 years of mortality due to chronic obstructive pulmonary disease in Australia: the role of tobacco consumption. Int J Tuberc Lung Dis (2012) 0.79

Analysis of a human fetal pancreatic islet cell line. Transplant Proc (1997) 0.78

Maturation and function of human fetal pancreatic cells after cryopreservation. Transplantation (1993) 0.78

Intrapancreatic islet transplantation in experimental diabetes in the rat. Metabolism (1992) 0.78

Development of a cell line from the human fetal pancreas. Transplant Proc (1995) 0.78

Development of a VSV-G protein pseudotyped retroviral vector system expressing dominant oncogenes from a lacO-modified inducible LTR promoter. Gene (1996) 0.77

Health for all: analyzing health status and determinants. World Health Stat Q (1998) 0.77

International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the United States. Ann N Y Acad Sci (1990) 0.77

Use of hepatocyte growth factor/scatter factor to increase transplantable human fetal islet cell mass. Transplant Proc (1994) 0.77

Differential integrin expression facilitates isolation of human fetal pancreatic epithelial cells. Cell Transplant (1994) 0.76

Angiogenic peptides in pancreatic islet transplantation to diabetic rats. Transplantation (1990) 0.76

In vivo maturation and growth potential of human fetal pancreases: fresh versus cultured tissue. Transplant Proc (1995) 0.76

Investigating Australia's burden of disease. Med J Aust (2000) 0.75

The impact of demographic trends on health: introduction. World Health Stat Q (1987) 0.75

A leukemia virus-related protein in the murine pancreas. Biochem Biophys Res Commun (1984) 0.75

Health outlook for South and East Asia for the year 2000. World Health Stat Q (1981) 0.75